======= AK2 ======= == Gene Information == * **Official Symbol**: AK2 * **Official Name**: adenylate kinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=204|204]] * **UniProt**: [[https://www.uniprot.org/uniprot/P54819|P54819]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/103020|Open OMIM]] == Function Summary == * **Entrez Summary**: Adenylate kinases are involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. Three isozymes of adenylate kinase, namely 1, 2, and 3, have been identified in vertebrates; this gene encodes isozyme 2. Expression of these isozymes is tissue-specific and developmentally regulated. Isozyme 2 is localized in the mitochondrial intermembrane space and may play a role in apoptosis. Mutations in this gene are the cause of reticular dysgenesis. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 1 and 2.[provided by RefSeq, Nov 2010]. * **UniProt Summary**: N/A |ADK| |ADK lid| |sperm mitochondrial sheath| |ADP biosynthetic process| |purine nucleoside diphosphate biosynthetic process| |ribonucleoside diphosphate biosynthetic process| |purine ribonucleoside diphosphate biosynthetic process| |adenylate kinase activity| |nucleoside diphosphate biosynthetic process| |AMP metabolic process| |nucleoside monophosphate phosphorylation| |nucleobase-containing small molecule interconversion| |purine ribonucleoside monophosphate metabolic process| |purine nucleoside monophosphate metabolic process| |ADP metabolic process| |ribonucleoside monophosphate metabolic process| |purine nucleoside diphosphate metabolic process| |purine ribonucleoside diphosphate metabolic process| |ribonucleoside diphosphate metabolic process| |nucleoside monophosphate metabolic process| |mitochondrial intermembrane space| |nucleoside diphosphate metabolic process| |purine ribonucleotide biosynthetic process| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |ATP metabolic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |drug metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |carbohydrate derivative biosynthetic process| |organophosphate metabolic process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |phosphorylation| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.9| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.8| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.72| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.9| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.92| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|2.18| |[[:results:exp332|Adefovir 20μM R07 exp332]]|2.24| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|2.29| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.33| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.55| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.91| |[[:results:exp211|AICAR 240μM R05 exp211]]|8.09| |[[:results:exp116|AICAR 240μM R03 exp116]]|8.26| ^Gene^Correlation^ |[[:human genes:n:nudt2|NUDT2]]|0.539| |[[:human genes:m:mtr|MTR]]|0.477| |[[:human genes:a:adss|ADSS]]|0.477| |[[:human genes:m:mmachc|MMACHC]]|0.444| |[[:human genes:y:ylpm1|YLPM1]]|0.421| |[[:human genes:a:adk|ADK]]|0.412| |[[:human genes:s:slc25a32|SLC25A32]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2747 * **Expression level (log2 read counts)**: 7.93 {{:chemogenomics:nalm6 dist.png?nolink |}}